{"id":14559,"date":"2016-08-24T21:16:17","date_gmt":"2016-08-24T21:16:17","guid":{"rendered":"https:\/\/www.china-certification.com\/en\/?page_id=705"},"modified":"2023-02-09T11:44:50","modified_gmt":"2023-02-09T10:44:50","slug":"cfda-priority-review-procedure-for-medical-devices","status":"publish","type":"post","link":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/","title":{"rendered":"CFDA: Priority Review Procedure for Medical Devices"},"content":{"rendered":"<div id=\"fb-root\">The <strong>China Food and Drug Administration<\/strong> (CFDA) issued a draft of regulation for <strong>priority review<\/strong> for medical device manufacturers. The circular proposes the qualifying criteria, process and features of the priority review. The public was able to comment the draft until July 20th 2016.<\/div>\n<p>In China it is necessary that manufacturers of class II and class III medical devices follow a strict technical review. This technical review is done by the <strong>Centre for Medical Device Evaluation<\/strong> (CMDE). This is necessary before the devices can be shipped to China.<\/p>\n<p>The priority review should give the applicants shorter review time in the registration process. According to the circular, applicants with class II medical devices (only foreign applicants) or class III medical device manufacturers (both domestic and foreign applicants) can request a priority review in some cases. First of all, a priority review is possible if the device is part of the National Science and Technology Major Project or the National Key Research and Development Plan. Priority review is also possible if a medical device can:<\/p>\n<ul>\n<li>diagnose or treat a rare disease and has outstanding advantages in clinical practice<\/li>\n<li>diagnose or treat malignant tumors and has outstanding advantages in clinical practice<\/li>\n<li>diagnose or treat a specific disease that frequently occurs in the elderly and there is no other effective way to diagnose or cure such disease<\/li>\n<li>diagnose or treat a specific disease that frequently occurs in children and there is no other effective way to diagnose or cure such disease<\/li>\n<li>address an urgent clinical need and the same type of device has not yet been marketed in China<\/li>\n<\/ul>\n<p>The CMDE will decide whether a specific medical device is able to receive priority review. If a device is not eligible to receive priority review, they have to follow the standard review process. If a device receives priority review the applicant is able to make use of features which shorten the technical review process. As it can be seen, the CFDA is trying to introduce new approaches which can improve the registration process. Therefore, medical device manufacturers should monitor changes constantly.<\/p>\n<p>Please do not hesitate to call (UK: <strong>+44 2071931135<\/strong>, Rest of Europe: <strong>+49 69 2713769150<\/strong>, US: <strong>+1 773 654-2673<\/strong>) or <a href=\"mailto:info@china-certification.com\"><strong>email<\/strong><\/a> and we will be happy to answer questions.<\/p>\n<div class=\"fb-like\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>The China Food and Drug Administration (CFDA) issued a draft of regulation for priority review for medical device manufacturers. The circular proposes the qualifying criteria, process and features of the priority review. The public was able to comment the draft until July 20th 2016. In China it is necessary that manufacturers of class II and [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[106],"tags":[],"class_list":["post-14559","post","type-post","status-publish","format-standard","hentry","category-further-topics"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CFDA: Priority Review Procedure for Medical Devices - MPR China Certification GmbH<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CFDA: Priority Review Procedure for Medical Devices - MPR China Certification GmbH\" \/>\n<meta property=\"og:description\" content=\"The China Food and Drug Administration (CFDA) issued a draft of regulation for priority review for medical device manufacturers. The circular proposes the qualifying criteria, process and features of the priority review. The public was able to comment the draft until July 20th 2016. In China it is necessary that manufacturers of class II and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/\" \/>\n<meta property=\"og:site_name\" content=\"MPR China Certification GmbH\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-24T21:16:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-09T10:44:50+00:00\" \/>\n<meta name=\"author\" content=\"Julian Busch\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Julian Busch\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-priority-review-procedure-for-medical-devices\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-priority-review-procedure-for-medical-devices\\\/\"},\"author\":{\"name\":\"Julian Busch\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#\\\/schema\\\/person\\\/4f5cd923141741b7fe96721b17c464bf\"},\"headline\":\"CFDA: Priority Review Procedure for Medical Devices\",\"datePublished\":\"2016-08-24T21:16:17+00:00\",\"dateModified\":\"2023-02-09T10:44:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-priority-review-procedure-for-medical-devices\\\/\"},\"wordCount\":374,\"articleSection\":[\"Further Topics\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-priority-review-procedure-for-medical-devices\\\/\",\"url\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-priority-review-procedure-for-medical-devices\\\/\",\"name\":\"CFDA: Priority Review Procedure for Medical Devices - MPR China Certification GmbH\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#website\"},\"datePublished\":\"2016-08-24T21:16:17+00:00\",\"dateModified\":\"2023-02-09T10:44:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#\\\/schema\\\/person\\\/4f5cd923141741b7fe96721b17c464bf\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-priority-review-procedure-for-medical-devices\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-priority-review-procedure-for-medical-devices\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/cfda-priority-review-procedure-for-medical-devices\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CFDA: Priority Review Procedure for Medical Devices\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/\",\"name\":\"MPR China Certification GmbH\",\"description\":\"Consulting and Implementation of Certification Projects for China, Korea and India.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.china-certification.com\\\/fr\\\/#\\\/schema\\\/person\\\/4f5cd923141741b7fe96721b17c464bf\",\"name\":\"Julian Busch\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g\",\"caption\":\"Julian Busch\"},\"description\":\"About the author: Louis Gogger is Managing Director of MPR China Certification GmbH Publisher: MPR China Certification GmbH Tel.: +49 69 271 37 69 150 E-Mail: info@china-certification.com Web: www.china-certification.com\",\"url\":\"https:\\\/\\\/www.china-certification.com\\\/en\\\/author\\\/julian-busch\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CFDA: Priority Review Procedure for Medical Devices - MPR China Certification GmbH","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/","og_locale":"en_US","og_type":"article","og_title":"CFDA: Priority Review Procedure for Medical Devices - MPR China Certification GmbH","og_description":"The China Food and Drug Administration (CFDA) issued a draft of regulation for priority review for medical device manufacturers. The circular proposes the qualifying criteria, process and features of the priority review. The public was able to comment the draft until July 20th 2016. In China it is necessary that manufacturers of class II and [&hellip;]","og_url":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/","og_site_name":"MPR China Certification GmbH","article_published_time":"2016-08-24T21:16:17+00:00","article_modified_time":"2023-02-09T10:44:50+00:00","author":"Julian Busch","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Julian Busch","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/#article","isPartOf":{"@id":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/"},"author":{"name":"Julian Busch","@id":"https:\/\/www.china-certification.com\/fr\/#\/schema\/person\/4f5cd923141741b7fe96721b17c464bf"},"headline":"CFDA: Priority Review Procedure for Medical Devices","datePublished":"2016-08-24T21:16:17+00:00","dateModified":"2023-02-09T10:44:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/"},"wordCount":374,"articleSection":["Further Topics"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/","url":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/","name":"CFDA: Priority Review Procedure for Medical Devices - MPR China Certification GmbH","isPartOf":{"@id":"https:\/\/www.china-certification.com\/fr\/#website"},"datePublished":"2016-08-24T21:16:17+00:00","dateModified":"2023-02-09T10:44:50+00:00","author":{"@id":"https:\/\/www.china-certification.com\/fr\/#\/schema\/person\/4f5cd923141741b7fe96721b17c464bf"},"breadcrumb":{"@id":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.china-certification.com\/en\/cfda-priority-review-procedure-for-medical-devices\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.china-certification.com\/en\/"},{"@type":"ListItem","position":2,"name":"CFDA: Priority Review Procedure for Medical Devices"}]},{"@type":"WebSite","@id":"https:\/\/www.china-certification.com\/fr\/#website","url":"https:\/\/www.china-certification.com\/fr\/","name":"MPR China Certification GmbH","description":"Consulting and Implementation of Certification Projects for China, Korea and India.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.china-certification.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.china-certification.com\/fr\/#\/schema\/person\/4f5cd923141741b7fe96721b17c464bf","name":"Julian Busch","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6fee0d05478aa57d981a6df656f31db4d333de96110871cea6b777cef378a3a2?s=96&d=mm&r=g","caption":"Julian Busch"},"description":"About the author: Louis Gogger is Managing Director of MPR China Certification GmbH Publisher: MPR China Certification GmbH Tel.: +49 69 271 37 69 150 E-Mail: info@china-certification.com Web: www.china-certification.com","url":"https:\/\/www.china-certification.com\/en\/author\/julian-busch\/"}]}},"_links":{"self":[{"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/posts\/14559","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/comments?post=14559"}],"version-history":[{"count":1,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/posts\/14559\/revisions"}],"predecessor-version":[{"id":18888,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/posts\/14559\/revisions\/18888"}],"wp:attachment":[{"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/media?parent=14559"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/categories?post=14559"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.china-certification.com\/en\/wp-json\/wp\/v2\/tags?post=14559"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}